Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Auteurs » - entrée « Naomi Iwata »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Naomi Ichikawa < Naomi Iwata < Naomi Serling-Boyd  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000037 (2020) Masaki Shimizu [Japon] ; Mao Mizuta [Japon] ; Nami Okamoto [Japon] ; Takahiro Yasumi [Japon] ; Naomi Iwata [Japon] ; Hiroaki Umebayashi [Japon] ; Yuka Okura [Japon] ; Noriko Kinjo [Japon] ; Tomohiro Kubota [Japon] ; Yasuo Nakagishi [Japon] ; Kenichi Nishimura [Japon] ; Mariko Mohri [Japon] ; Masato Yashiro [Japon] ; Junko Yasumura [Japon] ; Hiroyuki Wakiguchi [Japon] ; Masaaki Mori [Japon]Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
000355 (2019) Ryuhei Yasuoka [Japon] ; Naomi Iwata [Japon] ; Naoki Abe [Japon] ; Toaki Kohagura [Japon] ; Haruna Nakaseko [Japon] ; Masaki Shimizu [Japon] ; Shinji Kawabe [Japon]Risk factors for hypersensitivity reactions to tocilizumab introduction in systemic juvenile idiopathic arthritis.
001328 (2014) Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu KishimotoLongterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.
001559 (2013) Shumpei Yokota ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu KishimotoLong-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan.
001612 (2013) Jun-Ichi Kawada [Japon] ; Yoshiro Kitagawa ; Naomi Iwata ; Yoshinori ItoClinical characteristics of influenza virus infection in juvenile idiopathic arthritis patients treated with tocilizumab.
001713 (2012) Tomoyuki Imagawa [Japon] ; Shumpei Yokota ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Hiroyuki Imanaka ; Yasuhito Nerome ; Naomi Iwata ; Takuji Murata ; Mari Miyoshi ; Norihiro Nishimoto ; Tadamitsu KishimotoSafety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis.
001728 (2012) Jun-Ichi Kawada [Japon] ; Naomi Iwata ; Yoshiro Kitagawa ; Hiroshi Kimura ; Yoshinori ItoProspective monitoring of Epstein-Barr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated with methotrexate and tocilizumab.
001B61 (2008) Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Yukoh Aihara ; Shuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu KishimotoEfficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Naomi Iwata" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Naomi Iwata" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Naomi Iwata
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021